学者信息

夏琳 (Lin Xia)

药学院

合作者

已发表成果:

WOK 论文 5 篇;

  • A SARS-CoV-2-specific CAR-T-cell model identifies felodipine, fasudil, imatinib, and caspofungin as potential treatments for lethal COVID-19

    CELLULAR & MOLECULAR IMMUNOLOGY,1672-7681,2023-03.
    Xia, Lin; Yuan, Lun-Zhi; Hu, Ya-Hong; Liu, Jun-Yi; Hu, Guo-Sheng; Qi, Ruo-Yao; Zhang, Tian-Ying; Xi...
    WOS:000942953000001   10.1038/s41423-023-00985-3
    收录情况:SCIE
  • Super-enhancer-controlled positive feedback loop BRD4/ER alpha-RET-ER alpha promotes ER alpha-positive breast cancer

    NUCLEIC ACIDS RESEARCH,0305-1048,2022-09.
    Zheng, Zao-zao; Xia, Lin; Hu, Guo-sheng; Liu, Jun-yi; Hu, Ya-hong; Chen, Yu-jie; Peng, Jia-yin; Zha...
    WOS:000858410200001   10.1093/nar/gkac778
    收录情况:SCIE
  • BRD4 inhibition boosts the therapeutic effects of epidermal growth factor receptor-targeted chimeric antigen receptor T cells in glioblastoma

    MOLECULAR THERAPY,1525-0016,2021-10-06.
    Xia, Lin; Liu, Jun-yi; Zheng, Zao-zao; Chen, Yu-jie; Ding, Jian-cheng; Hu, Ya-hong; Hu, Guo-sheng; ...
    WOS:000708411300004   10.1016/j.ymthe.2021.05.019
    收录情况:SCIE
  • Targeting Triple-Negative Breast Cancer with Combination Therapy of EGFR CAR T Cells and CDK7 Inhibition

    CANCER IMMUNOLOGY RESEARCH,2326-6066,2021-06-01.
    Xia, Lin; Zheng, Zaozao; Liu, Jun-Yi; Chen, Yu-Jie; Ding, Jiancheng; Hu, Guo-Sheng; Hu, Ya-Hong; Li...
    WOS:000659292000011   10.1158/2326-6066.CIR-20-0405
    收录情况:SCIE
  • EGFR-targeted CAR-T cells are potent and specific in suppressing triple-negative breast cancer both in vitro and in vivo

    CLINICAL & TRANSLATIONAL IMMUNOLOGY,,2020-05.
    Xia, Lin; Zheng, Zao-Zao; Liu, Jun-Yi; Chen, Yu-Jie; Ding, Jian-Cheng; Xia, Ning-Shao; Luo, Wen-Xin...
    WOS:000537716300007   10.1002/cti2.1135
    收录情况:SCIE